2021
DOI: 10.1093/narcan/zcab015
|View full text |Cite
|
Sign up to set email alerts
|

Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses

Abstract: Arming oncolytic adenoviruses with therapeutic transgenes is a well-established strategy for multimodal tumour attack. However, this strategy sometimes leads to unexpected attenuated viral replication and a loss of oncolytic effects, preventing these viruses from reaching the clinic. Previous work has shown that altering codon usage in viral genes can hamper viral fitness. Here, we have analysed how transgene codon usage impacts viral replication and oncolytic activity. We observe that, although transgenes wit… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 29 publications
(35 reference statements)
0
3
0
Order By: Relevance
“…This contradicts the recommendation to use optimal host codons in transgenes to maximize gene expression. The study investigates the impact of transgene codon usage on viral fitness and finds that transgenes with higher GC3 content (optimal codon usage) have higher gene expression and viral replication, while those with lower GC3 content have lower expression and replication ( Núñez-Manchón et al, 2021 ). By tuning the codon usage of transgenes, it is possible to achieve better transgene expression without compromising viral replication, thus optimizing the therapeutic outcome.…”
Section: Codon Optimization For Gene Therapy Vectorsmentioning
confidence: 99%
“…This contradicts the recommendation to use optimal host codons in transgenes to maximize gene expression. The study investigates the impact of transgene codon usage on viral fitness and finds that transgenes with higher GC3 content (optimal codon usage) have higher gene expression and viral replication, while those with lower GC3 content have lower expression and replication ( Núñez-Manchón et al, 2021 ). By tuning the codon usage of transgenes, it is possible to achieve better transgene expression without compromising viral replication, thus optimizing the therapeutic outcome.…”
Section: Codon Optimization For Gene Therapy Vectorsmentioning
confidence: 99%
“…The oligonucleotide sequences are available in Table S3. Annealed oligos were phosphorylated by T4 PNK (NEB) and inserted in the 3 UTR of the EGFP in the miRVec-EGFP plasmid overnight at 4 • C [16]. Plasmid constructions (miRVec-miR222-S and miRVec-Scramble) were tested by PCR using primer set miRVec_Val (Table S2), and positive colonies confirmed by Sanger Sequencing (Genewitz).…”
Section: Mirna Sponge Generationmentioning
confidence: 99%
“…This in part motivates our focus on codon composition (as opposed to, for example general 5' stability) as transgene design algorithms commonly employ codon-level metrics to determine which synonymous site to employ within the transgene, sometimes in a gene position specific manner (e.g. [65][66][67]). Second, while CAI provides a useful surrogate for expression level of a gene in some species [8,36], understanding IO scores could augment such a metric providing a better proxy of protein abundance, potentially applicable also in species in which there is no evidence for translational selection [36] and no (hard to obtain) protein level measures.…”
Section: Introductionmentioning
confidence: 99%